Advertisement

Intereconomics

, Volume 37, Issue 3, pp 150–155 | Cite as

Economic insights and deficits in European biotechnology patent policy

  • Bernard Michael Gilroy
  • Tobias Volpert
Patent Law
  • 49 Downloads

Abstract

The decisive statutory provision of the EU for patent protection of genetic engineering inventions is the so-called directive on biotechnological patents (DBP). Its objective is the encouragement of research and development in the genetic engineering sector. The following exposition shows that the DBP has two major flaws from the economist's point of view, under which particularly small and medium-sized enterprises, the driving force of this young line of business, suffer.

Keywords

Patent Protection European Patent Patent System Patent Office Basic Innovation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    cf. e.g. M. H. Dunn: Wachstum und endogener technologischer Wandel, in: ORDO, Jahrbuch für die Ordnung von Wirtschaft und Gesellschaft, Vol. 51, 2000, pp. 277–299.Google Scholar
  2. 2.
    Definitions vary in detail., Cf. e.g., P. Klemperer: How broad should the scope of patent protection be?, in: The RAND Journal of Economics, Vol. 21, No. 1, 1990, pp. 113–130.Google Scholar
  3. 4.
    C. Luttermann: Patentschutz für Biotechnologie. Die europäische Richtlinie über den rechtlichen Schutz biotechnologischer Erfindungen, in: Recht der internationalen Wirtschaft, Vol. 44, No. 12, 1998, pp. 916–920.Google Scholar
  4. 6.
    Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, in: Official Journal of the European Communities, L 213, Vol. 41, 1998, pp. 13–21.Google Scholar
  5. 7.
    T. Kienle: Die neue EU-Richtlinie zum Schutz biotechnologischer Erfindungen—Rechtliche und ethische Probleme der Patentierung biologischer Substanzen, in: Europäisches Wirtschafts- & Steuerrecht, Vol. 9, No. 5, 1998, pp. 156–162; Directive 98/44/EC, op. cit. of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, in: Official Journal of the European Communities, Article 3, para. 2.Google Scholar
  6. 8.
    C. Luttermann, op. cit., Patentschutz für Biotechnologie. Die europäische Richtlinie über den rechtlichen Schutz biotechnologischer Erfindungen, in: Recht der internationalen Wirtschaft, Vol. 44, No. 12, 1998, pp. 918.Google Scholar
  7. 9.
    Directive 98/44/EC, op. cit., of the European Parliament and of the Council of 6 July 1998 on the legal protection of b biotechnological inventions, in: Official Journal of the European Communities Article 2, para. 1 (a).Google Scholar
  8. 10.
    H. F. Chang: Patent scope, antitrust policy, and cumulative innovation, in: The RAND Journal of Economics, Vol. 26, No. 1, 1995, pp. 34–57.Google Scholar
  9. 11.
    V. Denicolo: The optimal life of a patent when the timing of innovation is stochastic, in: International Journal of Industrial Organization, Vol. 17, No. 6, 1999, pp. 827–846; R. Gilbert, C. Shapiro: Optimal patent length and breadth, in: The RAND Journal of Economics, Vol. 21, No. 1, 1990, pp. 106–112.Google Scholar
  10. 12.
    T. Eger, P. Weise: Innovation, Imitation und Patentrecht im Systemvergleich, in: H. E. Gramatzki, F. Klinger, H. G. Nutzinger (eds.): Wissenschaft, Technik und Arbeit: Innovationen in Ost und West, Kassel 1990, VWL-inform, pp. 107–133.Google Scholar
  11. 14.
    J. Lerner: The importance of patent scope: an empirical analysis, in: RAND Journal of Economics, Vol. 25, No. 2, 1994, pp. 319–333.Google Scholar
  12. 16.
    C. Matutes, P. Regibeau, K. Rockett: Optimal patent design and the diffusion of innovations, in: The RAND Journal of Economics, Vol. 27, No. 1, 1996, pp. 60–83.Google Scholar
  13. 17.
    Directive 98/44/EC, op. cit., of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, in: Official Journal of the European Communities, Article 3, para. 1.Google Scholar
  14. 18.
    M. Plimier: Genetech, Inc. v. Novo Nordisk & University of California v. Eli Lilly And Co., in: Berkeley Technology Law Journal, Vol. 13, No. 1, 1998, pp. 149–161.Google Scholar
  15. 19.
    M. Waterson: The Economics of Product Patents, in: The American Economic Review, Vol. 80, No. 4, 1990, pp. 860–869; G. Llobet: Patent Design under the Threat of Litigation, in: Asociation Argentina De Economia Politica (ed.): The Twelfth World Congress Of The International Economic Association, Buenos Aires 1999 (CD Rom).Google Scholar
  16. 20.
    H. D. Karl, L. Scholz, G. Wiesner: Biotechnologie—Abbau von Investitionshemmnissen im staatlichen Einflußbereich, in: ifo Schnelldienst, Vol. 42, No. 22, 1989, pp. 9–20.Google Scholar
  17. 22.
    G. Vita: Wachstumsindustrie Gen- und Biotechnologie, Life Sciences als internationale Zukunftschance, in: Internationale Politik, Vol. 53, No. 8, 1998, pp. 7–14.Google Scholar
  18. 23.
    M. Kiper: Trendwende in der Gentechnik: Fiktion oder Realität? Zu den wirtschaftlichen und gesellschaftlichen Perspektiven der Genund Biotechnologie, in: WSI Mitteilungen, Vol. 51, No. 2, 1998, pp. 115–122.Google Scholar
  19. 24.
    Bio Technologie—Das Jahr- und Adreßbuch 2001, Vol. 15, Berlin 2000, Biocom-Verlag.Google Scholar
  20. 25.
    Europäisches Patentamt (ed.): Nutzung des Patentschutzes in Europa: Repräsentative Erhebung erstellt im Auftrag des Europäischen Patentamts; Schriftenreihe des Europäischen Patentamtes, Vol. 3, Munich 1994; H. D. Karl, L. Scholz, G. Wiesner, op. cit., Biotechnologie—Abbau von Investitionshemmnissen im staatlichen Einflußbereich, in: Ifo Schnelldienst, Vol. 42, No. 22, 1989, p. 14.Google Scholar

Copyright information

© HWWA and Springer-Verlag 2002

Authors and Affiliations

  • Bernard Michael Gilroy
    • 1
  • Tobias Volpert
    • 1
  1. 1.University of PaderbornGermany

Personalised recommendations